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demonstrated by studies of the burden to iron-overloaded
patients receiving infused-ICT. Administration of infused-ICT
was time-consuming, inconvenient, negatively impacted patients’
HRQoL, and up to 50% of UK patients had suboptimal treat-
ment adherence, compromising morbidity and mortality. PROs
in phase II/III clinical trials comparing the efﬁcacy and safety of
deferasirox with infused-ICT revealed that at each timepoint
signiﬁcantly more patients were ‘satisﬁed or very satisﬁed’ with
deferasirox or found it to be ‘convenient or very convenient’
compared to previously received infused-ICT. Fewer hours were
lost from daily activities, 77% preferred deferasirox, and more
patients were willing to continue taking deferasirox than infused-
ICT (84% vs. 11%). The French Transparency Commission
acknowledged moderate improvement in medical beneﬁt for
deferasirox versus infused ICT considering improved HRQoL
and adherence to ICT. Use of deferasirox is recommended.
CONCLUSIONS: PROs can increase key stakeholders’ aware-
ness addressing concerns such as the medical importance of
disease and unmet needs, the therapeutic value of products, and
the beneﬁts over existing treatments from the patient perspective.
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OBJECTIVES: Quality-adjusted life-years (QALYs) measure the
number of years of perfect health provided by a health care
intervention, and are a useful measure because they combine
mortality and morbidity in one scale. QALYS are considered the
“gold-standard” for assessing the effectiveness, and thus cost-
effectiveness, of new interventions and are requested by most
reimbursement agencies, such as the UK NICE. Utility data (gen-
erally gained through quality-of-life instruments) are required to
calculate QALYs, however such data may not be available for
some drug indications. As a result, these drug indications are not
suitable for assessment via QALYs.We sought to clarify the extent
to which this is a problem. METHODS: We reviewed all prescrip-
tion drugs (including new preparations of existing drugs)
approved by the UK regulatory agency, the MHRA. Using an
online database of utility scores from Tufts University, we con-
ducted various descriptive analyses. Our primary analysis was to
establish the percentage of licensed drugs for which utility scores
are available and thus for which QALYs are a possible effective-
ness measure. RESULTS: Interim analysis of 93 licensed prepara-
tions showed that 73% had utility data available. This leaves a
substantial proportion of drugs for which QALYs may be difﬁcult
or impossible to obtain. Where QALYs are difﬁcult to obtain, this
may limit the conﬁdence with which they can be interpreted. In
other cases, QALYs may be irrelevant: these include important
indications such as anaesthesia and contraception. CONCLU-
SIONS: It is important for reimbursement agencies to recognise
that QALYs are not a universal measure, and that ﬂexibility is
required for indications in which QALYs cannot be used. An
over-emphasis on QALYs may lead to a bias against positive
recommendations in disease areas where QALYS cannot be used.
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OBJECTIVES: Inﬂuential health psychology models consider the
social context of health beliefs and their inﬂuence on medication
uptake and adherence. We conducted a systematic literature
review to identify how widely three social cognition models have
been used in transplantation and whether consideration of such
psychological factors can improve adherence to immunosuppres-
sion therapy and, consequently, the success of the transplanta-
tion. METHODS: Systematic searches were undertaken in
SCOPUS. Three social cognition models (Health Belief Model
(HBM), Theory of Reasoned Action (TRA), and Social Learning
Theory (SLT)) were paired with the search terms “transplant*”
and “immunosuppress*” in a fully inclusive search (since 1966).
RESULTS: The HBM has been used only once in transplant
research, related to adherence with immunosuppression regimens
in kidney transplant (N = 110). The study concluded that inter-
ventional strategies to increase adherence will need to consider
the variables of the HBM in order to maximise success. The TRA
has been used only twice in transplantation, on both occasions in
the general population to elicit views on organ donation. One
study (N = 298) examined reluctance to discuss organ donation
with family members. Intentions, attitudes, subjective norms,
death anxiety, and knowledge were important when reducing
communication barriers. The aim of the second study was to
investigate knowledge, behaviour and normative beliefs of stu-
dents concerning transplant and organ donations, based on the
TRA (N = 94). SLT has not been explored in transplantation but
is highlighted as a valid method for providing professional
support to live kidney donors before and after surgery. CON-
CLUSIONS: Social cognition models include a variety of psycho-
logical factors that can aid our understanding of medication
adherence. However, they have not been used widely in trans-
plant populations. Use of such models can encourage discussion
about sensitive issues surrounding organ donation and is likely to
maximise adherence to immunosuppression medication for those
undergoing transplantation.
PMC47
A STUDY OFTHE KEY FACTORS INFLUENCINGTHE PATIENT
SATISFACTION IN INPATIENT AND OUTPATIENT SETTINGS
Tsai SF, Yeh GC
Taipei Medical University Hospital,Taipei,Taiwan
OBJECTIVES: This study was conducted in April 2007 at the
Taipei Medical University Hospital, which is a district teaching
hospital in Taiwan. The purpose of this study is to identify the
most important determinants of the Patient satisfaction in the
inpatient and outpatient settings. METHODS: Patient satisfac-
tion was measured in a self written survey of inpatient and
outpatient setting with the structured questionnaire including
demography, environment, service manner, administration efﬁ-
ciency, process of diagnosis and treatment. This study collected
data of 201 outpatient and 186 inpatient and were analysed with
SPSS package. Stepwise regression analysis were conducted to
help identify which factors were the most important in determin-
ing and chosen to make the best predicting model for patient
satisfaction. RESULTS: Patients were generally satisﬁed with the
mean score 4.12 and 3.77 in inpatient and outpatient respectively
(scale 1 to 5, 5 being most satisﬁed). Through the stepwise
regression analysis, in inpatient setting, the best ﬁt for patient
satisfaction standardized predicting model is : Patient Satisfac-
tion(Y) = 0.997 disease relieved (R2 = 0.954, F = 352.23.
P < 0.001); In outpatient setting, the best ﬁt for patient satis-
faction standardized predicting model is: Patient Satisfac-
tion(Y) = 0.255 hear patient reporting their condition with
patient +0.249 manner of examination services +0.194 symp-
toms relieved +0.179 the air and the light of the hospital +0.169
waiting time for the diagnosis test report (R2 = 0.666, F = 33.90,
P < 0.001). CONCLUSIONS: The results reveal that the patient
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